Not applicableStudy completedNCT03958461What this trial is testingConnection Between Periodontitis and Exudative Age-related Macular DegenerationWho this might be right forPeriodontitis University of Helsinki 13
Large-scale testing (Phase 3)Looking for participantsNCT03683251What this trial is testingExtension Study for the Port Delivery System With Ranibizumab (Portal)Who this might be right forNeovascular Age-Related Macular Degeneration Hoffmann-La Roche 1,000
Not applicableStudy completedNCT04847895What this trial is testingObservation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved IndicationsWho this might be right forNeovascular (Wet) Age-related Macular Degeneration Novartis Pharmaceuticals 5,500
Not applicableStudy completedNCT02218177What this trial is testingIntraocular Cytokines in Non-responders to Ranibizumab Treatment for Neovascular AMDWho this might be right forAge Related Macular Degeneration University Health Network, Toronto 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05562947What this trial is testingThe Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD)Who this might be right forNeovascular Age-related Macular DegenerationnAMD Hoffmann-La Roche 68
Testing effectiveness (Phase 2)Ended earlyNCT00347399What this trial is testingBevacizumab and Photodynamic Therapy in Neovascular Age Related Macular DegenerationWho this might be right forAge Related Macular Degeneration Asociación para Evitar la Ceguera en México 25
Testing effectiveness (Phase 2)Study completedNCT05891548What this trial is testingStudy to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular DegenerationWho this might be right forNeovascular Age-related Macular Degeneration Clearside Biomedical, Inc. 60
Large-scale testing (Phase 3)Study completedNCT03823300What this trial is testingEvaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)Who this might be right forWet Macular Degeneration Hoffmann-La Roche 658
Post-approval studies (Phase 4)Study completedNCT01896284What this trial is testingStudy to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth FactorWho this might be right forWet Macular Degeneration Barcelona Macula Foundation 46
Early research (Phase 1)WithdrawnNCT01177644What this trial is testingSafety and Preliminary Efficacy Study of PDS-1.0 in Patients With Neovascular AMDWho this might be right forAge-Related Macular Degeneration Forsight Vision4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07798375What this trial is testingEvaluate the Efficacy and Safety of VIS-101 in Participants With Neovascular Age-Related Macular DegenerationWho this might be right forNeovascular Age Related Macular Degeneration(nAMD) Everest Medicines (China) Co.,Ltd. 244
Not applicableUnknownNCT00380172What this trial is testingLong-Term Efficacy in AMD of Rheopheresis in North AmericaWho this might be right forMacular Degeneration OccuLogix 120
Not applicableNot Yet RecruitingNCT06759597What this trial is testingThe Effect of Phacoemulsification on the Macular Changes in Patients with Neovascular Age-related Macular DegenerationWho this might be right forNeovascular (wet) Age-Related Macular Degeneration Assiut University 50
Not applicableUnknownNCT03893474What this trial is testingQuality-Assured Follow-up of Quiescent Neovascular Age -Related maculaR dEgeneration by Non-medical PractitionersWho this might be right forAMD Moorfields Eye Hospital NHS Foundation Trust 742
Testing effectiveness (Phase 2)Study completedNCT03362190What this trial is testingZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD)Who this might be right forNeovascular Age-related Macular Degeneration Ophthotech Corporation 64
Not applicableUnknownNCT02089503What this trial is testingMonocentric Retrospective Observational Study on Patients With Macular DegenerationWho this might be right forExudative Age-Related Macular Degeneration Hospital St. Joseph, Marseille, France 250
Not applicableLooking for participantsNCT07004361What this trial is testingEthical Issues of Using Gene Therapy in the Treatment of AMDWho this might be right forExudative Age-related Macular Degeneration Nantes University Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07178249What this trial is testingEvaluating the Safety and Preliminary Efficacy of EXG202 Gene Therapy for Neovascular AMDWho this might be right forWet Age-related Macular Degeneration Guangzhou Jiayin Biotech Ltd 60
Early research (Phase 1)UnknownNCT00767949What this trial is testingSafety Study of iSONEP (Sonepcizumab/LT1009) to Treat Neovascular Age-related Macular DegenerationWho this might be right forNeovascular Age Related Macular Degeneration Lpath, Inc. 15
Large-scale testing (Phase 3)UnknownNCT04667039What this trial is testingEfficacy, Safety, pharmacokinetiсs, Immunogenicity of GNR-067 and Lucentis®Who this might be right forAge Related Macular Degeneration (ARMD) AO GENERIUM 408